These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7473144)

  • 21. Effects of selected histamine H3 receptor antagonists on tele-methylhistamine levels in rat cerebral cortex.
    Yates SL; Tedford CE; Gregory R; Pawlowski GP; Handley MK; Boyd DL; Hough LB
    Biochem Pharmacol; 1999 May; 57(9):1059-66. PubMed ID: 10796076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.
    Esbenshade TA; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Fox GB; Faghih R; Bennani YL; Williams M; Hancock AA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):887-96. PubMed ID: 12606603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight.
    Malmlöf K; Zaragoza F; Golozoubova V; Refsgaard HH; Cremers T; Raun K; Wulff BS; Johansen PB; Westerink B; Rimvall K
    Int J Obes (Lond); 2005 Dec; 29(12):1402-12. PubMed ID: 16151415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives.
    Kovalainen JT; Christiaans JA; Kotisaari S; Laitinen JT; Männistö PT; Tuomisto L; Gynther J
    J Med Chem; 1999 Apr; 42(7):1193-202. PubMed ID: 10197963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical acetylcholine release elicited by stimulation of histamine H1 receptors in the nucleus basalis magnocellularis: a dual-probe microdialysis study in the freely moving rat.
    Cecchi M; Passani MB; Bacciottini L; Mannaioni PF; Blandina P
    Eur J Neurosci; 2001 Jan; 13(1):68-78. PubMed ID: 11135005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain.
    Pelloux-Léon N; Fkyerat A; Piripitsi A; Tertiuk W; Schunack W; Stark H; Garbarg M; Ligneau X; Arrang JM; Schwartz JC; Ganellin CR
    J Med Chem; 2004 Jun; 47(12):3264-74. PubMed ID: 15163206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Search for novel leads for histamine H3-receptor antagonists: amine derivatives.
    Stark H; Ligneau X; Lipp R; Arrang JM; Schwartz JC; Schunack W
    Pharmazie; 1997 Jun; 52(6):419-23. PubMed ID: 9260265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors.
    Ligneau X; Garbarg M; Vizuete ML; Diaz J; Purand K; Stark H; Schunack W; Schwartz JC
    J Pharmacol Exp Ther; 1994 Oct; 271(1):452-9. PubMed ID: 7965746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats.
    Medhurst AD; Briggs MA; Bruton G; Calver AR; Chessell I; Crook B; Davis JB; Davis RP; Foley AG; Heslop T; Hirst WD; Medhurst SJ; Ociepka S; Ray A; Regan CM; Sargent B; Schogger J; Stean TO; Trail BK; Upton N; White T; Orlek B; Wilson DM
    Biochem Pharmacol; 2007 Apr; 73(8):1182-94. PubMed ID: 17276409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography.
    Mezzomo K; Cumming P; Minuzzi L
    Eur J Pharmacol; 2007 Jun; 564(1-3):75-9. PubMed ID: 17350614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
    Sasse A; Kiec-Kononowicz K; Stark H; Motyl M; Reidemeister S; Ganellin CR; Ligneau X; Schwartz JC; Schunack W
    J Med Chem; 1999 Feb; 42(4):593-600. PubMed ID: 10052966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists.
    Liedtke S; Flau K; Kathmann M; Schlicker E; Stark H; Meier G; Schunack W
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):43-50. PubMed ID: 12616340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel carbamates as potent histamine H3 receptor antagonists with high in vitro and oral in vivo activity.
    Stark H; Purand K; Ligneau X; Rouleau A; Arrang JM; Garbarg M; Schwartz JC; Schunack W
    J Med Chem; 1996 Mar; 39(5):1157-63. PubMed ID: 8676353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ligands of the histamine H3-receptor: new potent antagonists of the 2-thioimidazole type.
    Plazzi PV; Mor M; Bordi F; Silva C; Rivara S; Caretta A; Ballabeni V; Impicciatore M; Vitali T
    Farmaco; 1997 May; 52(5):295-302. PubMed ID: 9274000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure.
    Stark H; Hüls A; Ligneau X; Purand K; Pertz H; Arrang JM; Schwartz JC; Schunack W
    Arch Pharm (Weinheim); 1998 Jun; 331(6):211-8. PubMed ID: 9713254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Selective stimulation of histamine H3 autoreceptors].
    Arrang JM; Garbarg M; Schwartz JC
    C R Acad Sci III; 1987; 304(1):11-4. PubMed ID: 3026590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of clozapine with the histamine H3 receptor in rat brain.
    Rodrigues AA; Jansen FP; Leurs R; Timmerman H; Prell GD
    Br J Pharmacol; 1995 Apr; 114(8):1523-4. PubMed ID: 7541279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imidazole H3-antagonists: relationship between structure and ex vivo binding to rat brain H3-receptors.
    Vacondio F; Mor M; Silva C; Zuliani V; Rivara M; Rivara S; Bordi F; Plazzi PV; Magnanini F; Bertoni S; Ballabeni V; Barocelli E; Carrupt PA; Testa B
    Eur J Pharm Sci; 2004 Sep; 23(1):89-98. PubMed ID: 15324926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of the specific binding of the histamine H3 receptor antagonist radioligand [3H]GR168320.
    Brown JD; O'Shaughnessy CT; Kilpatrick GJ; Scopes DI; Beswick P; Clitherow JW; Barnes JC
    Eur J Pharmacol; 1996 Sep; 311(2-3):305-10. PubMed ID: 8891613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of low level histamine H3 receptor occupancy by autoradiography.
    Le S; Finn JP; Larijani ME; Marino MJ; Schaffhauser H
    J Neurosci Methods; 2009 Dec; 185(1):70-5. PubMed ID: 19765611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.